Sands Capital wraps up third life sciences fund at $555m

Sands Capital Life Sciences Pulse Fund III will target private therapeutics, diagnostics, medical devices, and life sciences tools businesses.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this